Regeneration through Reprogramming Adult Cell Identity in Vivo

Derek K. Smith, Chun Li Zhang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The discovery and in vivo application of cell fate reprogramming concepts have jumpstarted new technologies aimed at the functional regeneration of damaged tissues. As most adult organ systems retain only a limited potential for self-regeneration after trauma, the production of fate-specific cells by in vivo transdifferentiation offers a targeted method for tissue bioengineering. Proof-of-principle studies have demonstrated the induction of neural precursor cells, neurons, cardiomyocytes, and insulin-producing β islet cells. Each of these induced cell types survive, mature, and integrate into the local environment in a functionally meaningful manner. Here, we briefly highlight recent advances in the in vivo reprogramming of cell identity and the current challenges that face the clinical relevance of these methods.

Original languageEnglish (US)
Article number2053
Pages (from-to)2619-2628
Number of pages10
JournalAmerican Journal of Pathology
Volume185
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Regeneration
Bioengineering
Islets of Langerhans
Cardiac Myocytes
Insulin
Technology
Neurons
Wounds and Injuries
Cellular Reprogramming

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Regeneration through Reprogramming Adult Cell Identity in Vivo. / Smith, Derek K.; Zhang, Chun Li.

In: American Journal of Pathology, Vol. 185, No. 10, 2053, 01.10.2015, p. 2619-2628.

Research output: Contribution to journalArticle

@article{c0f8b7a3b1f04fa99649da970051a904,
title = "Regeneration through Reprogramming Adult Cell Identity in Vivo",
abstract = "The discovery and in vivo application of cell fate reprogramming concepts have jumpstarted new technologies aimed at the functional regeneration of damaged tissues. As most adult organ systems retain only a limited potential for self-regeneration after trauma, the production of fate-specific cells by in vivo transdifferentiation offers a targeted method for tissue bioengineering. Proof-of-principle studies have demonstrated the induction of neural precursor cells, neurons, cardiomyocytes, and insulin-producing β islet cells. Each of these induced cell types survive, mature, and integrate into the local environment in a functionally meaningful manner. Here, we briefly highlight recent advances in the in vivo reprogramming of cell identity and the current challenges that face the clinical relevance of these methods.",
author = "Smith, {Derek K.} and Zhang, {Chun Li}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.ajpath.2015.02.025",
language = "English (US)",
volume = "185",
pages = "2619--2628",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Regeneration through Reprogramming Adult Cell Identity in Vivo

AU - Smith, Derek K.

AU - Zhang, Chun Li

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The discovery and in vivo application of cell fate reprogramming concepts have jumpstarted new technologies aimed at the functional regeneration of damaged tissues. As most adult organ systems retain only a limited potential for self-regeneration after trauma, the production of fate-specific cells by in vivo transdifferentiation offers a targeted method for tissue bioengineering. Proof-of-principle studies have demonstrated the induction of neural precursor cells, neurons, cardiomyocytes, and insulin-producing β islet cells. Each of these induced cell types survive, mature, and integrate into the local environment in a functionally meaningful manner. Here, we briefly highlight recent advances in the in vivo reprogramming of cell identity and the current challenges that face the clinical relevance of these methods.

AB - The discovery and in vivo application of cell fate reprogramming concepts have jumpstarted new technologies aimed at the functional regeneration of damaged tissues. As most adult organ systems retain only a limited potential for self-regeneration after trauma, the production of fate-specific cells by in vivo transdifferentiation offers a targeted method for tissue bioengineering. Proof-of-principle studies have demonstrated the induction of neural precursor cells, neurons, cardiomyocytes, and insulin-producing β islet cells. Each of these induced cell types survive, mature, and integrate into the local environment in a functionally meaningful manner. Here, we briefly highlight recent advances in the in vivo reprogramming of cell identity and the current challenges that face the clinical relevance of these methods.

UR - http://www.scopus.com/inward/record.url?scp=84943608359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943608359&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2015.02.025

DO - 10.1016/j.ajpath.2015.02.025

M3 - Article

C2 - 26056931

AN - SCOPUS:84943608359

VL - 185

SP - 2619

EP - 2628

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 10

M1 - 2053

ER -